In addition, we assessed the association of PROimpairment with histologic features of NASH and thepresence of DM. In this context, there was no associationwith the elements of Nonalcoholic Fatty Liver DiseaseActivity Score, ie, the grade of steatosis, lobular inflammation, or ballooning degeneration (SupplementaryTables 4,5, and 6). On the other hand, the PRO scoreswere significantly lower in NASH patients with type 2DM (P < .01 for physical health-related domains andPhysical Summary score of SF-36, EQ-5D utility, and 4out of 6 domains and the total score of CLDQ-NASH)(Supplementary Table 7).